Brain perfusion during rapid-eye-movement sleep successfully identifies amnestic mild cognitive impairment

Abstract Introduction Prodromal markers of Alzheimer’s disease (AD) have been derived from wakefulness. However, brain perfusion during rapid-eye movement (REM) sleep could be a sensitive marker of amnestic mild cognitive impairment (aMCI), as activation of REM sleep relies more on the cholinergic s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sleep medicine 2017-06, Vol.34, p.134-140
Hauptverfasser: Brayet, Pauline, Petit, Dominique, Baril, Andrée-Ann, Gosselin, Nadia, Gagnon, Jean-François, Soucy, Jean-Paul, Gauthier, Serge, Kergoat, Marie-Jeanne, Carrier, Julie, Rouleau, Isabelle, Montplaisir, Jacques
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction Prodromal markers of Alzheimer’s disease (AD) have been derived from wakefulness. However, brain perfusion during rapid-eye movement (REM) sleep could be a sensitive marker of amnestic mild cognitive impairment (aMCI), as activation of REM sleep relies more on the cholinergic system. Methods Eight subjects with aMCI, and 16 controls, underwent two single-photon emission computed tomography (SPECT) scans with tracer injected during REM sleep then wakefulness. Results Perfusion in the anterior cingulate cortex was significantly decreased in aMCI cases compared to controls for both conditions. That defect was much larger and more severe in REM sleep (1795 voxels) compared to wakefulness (398 voxels), and extended to the middle cingulate cortex and the olfactory cortex. Hypoperfusion in the anterior cingulate cortex during REM sleep allowed better classification than hypoperfusion found in wakefulness (93.8 vs 81.3%). Conclusion REM sleep imaging is a valuable tool with which to identify individuals at risk of developing AD.
ISSN:1389-9457
1878-5506
DOI:10.1016/j.sleep.2017.01.025